Potential Usefulness of Clopidogrel Pharmacogenetics in Ce rebral Endovascular Procedures and Carotid Artery Stenting-Reference-Cited by-同舟云学术

Potential Usefulness of Clopidogrel Pharmacogenetics in Ce rebral Endovascular Procedures and Carotid Artery Stenting

Published:2017-06-08 Issue:1 Volume:12 Page:
ISSN:1574-8847
Container-title:Current Clinical Pharmacology
language:en
Short-container-title:CCP

Author:

Duconge Jorge¹,Hernandez-Suarez Dagmar F.²

Affiliation:

1. Department of Pharmaceutical Sciences, University of Puerto Rico Medical Sciences Campus, School of Pharmacy, Room 325-14, PO Box 365067; San Juan, PR 00936-5067, Brazil

2. Department of Medicine, School of Medicine, University of Puerto Rico Medical Sciences Campus (UPR-MSC), San Juan, PR, Brazil

Publisher

Bentham Science Publishers Ltd.

Subject

Pharmacology (medical),General Pharmacology, Toxicology and Pharmaceutics,General Medicine

Cited by 17 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Preliminary outcomes of endovascular treatment of moyamoya disease;Neurología (English Edition);2024-07

2. Human Serum Albumin-enriched Clopidogrel Bisulfate Nanoparticle Alleviates Cerebral Ischemia–Reperfusion Injury in Rats;Pharmaceutical Research;2023-06-08

3. Clopidogrel hyper-response increases peripheral hemorrhagic complications without increasing intracranial complications in endovascular aneurysm treatments requiring dual antiplatelet therapy;Journal of Clinical Neuroscience;2022-11

4. Preliminary outcomes of endovascular treatment of moyamoya disease;Neurología;2022-01

5. Prevalence of CYP2C19 Polymorphisms in Clopidogrel Treated Turkish Patients: Preliminary Results, 2017;Current Pharmacogenomics and Personalized Medicine;2021-08